Top

Published in:

Open Access 01-06-2009 | Clinical trial updates and hotline sessions

Hotline sessions presented at the American College of Cardiology Congress 2009

Authors: Lars S. Maier, Magnus Baumhäkel, Michael Böhm

Published in: Clinical Research in Cardiology | Issue 6/2009

Abstract

The article summarizes the results of clinical trials in the field of cardiovascular medicine, which were presented during the Hotline Sessions at the annual meeting of the American College of Cardiology in Orlando, USA, from 28th March to 31st March 2009. The data were presented by leading experts in the field with relevant positions within the trials. Unpublished reports should be considered as preliminary data as the analysis may change in the final publications. The summaries presented in the manuscript were generated from the oral presentations and provide the readers with the comprehensive information on the results of the latest clinical trials in cardiovascular medicine.

Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N (2009) Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 373(9672):1341–1351PubMedCrossRef

Abraham WT, Burkhoff D, Nademanee K, Carson P, Bourge R, Ellenbogen KA, Parides M, Kadish A (2008) A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Am Heart J 156(4):641–648e1PubMedCrossRef

Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F (2009) Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360(14):1395–1407PubMedCrossRef

Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van THA, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK. (2009) Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (epub ahead of print)

Howard WV (1993) IV or IA lines? Anaesth Intensive Care 21(1):126–127PubMed

Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O’Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL (2009) Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360(17):1705–1717PubMedCrossRef

Mollmann H, Nef H, Bohm M, Laufs U (2009) Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association. Clin Res Cardiol 98(1):1–7PubMedCrossRef

Ndrepepa G, Braun S, Mehilli J, Niemoller K, Schomig A, Kastrati A (2007) A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Clin Res Cardiol 96(1):30–37PubMedCrossRef

Regitz-Zagrosek V, Gohlke-Barwolf C, Geibel-Zehender A, Haass M, Kaemmerer H, Kruck I, Nienaber C (2008) Heart diseases in pregnancy. Clin Res Cardiol 97(9):630–665PubMedCrossRef

10.

Rupp H (2006) Omega-3 fatty acids in secondary prevention after myocardial infarct. Clin Res Cardiol 95(Suppl 6):VI12–VI16PubMedCrossRef

11.

Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R (2008) Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358(21):2218–2230PubMedCrossRef

12.

Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G (2009) Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373(9673):1429–1439PubMedCrossRef

13.

Voller H (2006) Significance of changes in habits followed by risk reduction. Clin Res Cardiol 95(Suppl 6):VI6–VI11PubMedCrossRef

Title: Hotline sessions presented at the American College of Cardiology Congress 2009
Authors: Lars S. Maier
Magnus Baumhäkel
Michael Böhm
Publication date: 01-06-2009
Publisher: D. Steinkopff-Verlag
Published in: Clinical Research in Cardiology / Issue 6/2009
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-009-0023-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Hotline sessions presented at the American College of Cardiology Congress 2009

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2009

EUROSCORE: still gold standard or less?

Prevalence of ventricular discordance and its relation to functional capacity in idiopathic dilated cardiomyopathy

Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers

Reduction of neointimal hyperplasia in porcine coronary arteries by 2-deoxy-d-glucose

EuroSCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery

Laudatio anlässlich des 90. Geburtstages von Professor Dr.med. Dr.h.c. Franz Loogen